Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

Ryan D. Cassaday, MD, Lorinda A. Soma, MD, Olga Sala-Torra, MD, Philip A. Stevenson, MS, Mary-Elizabeth M. Percival, MD, Vivian G. Oehler, MD, Andrei R. Shustov, MD, Pamela S. Becker, MD, Anna B. Halpern, MD, Kelsey-Leigh Garcia, Christen N. Heye, ARNP, Jerald P. Radich, MD, Elihu H. Estey, MD

Blood (2018) 132 (Supplement 1): 1419.

https://doi.org/10.1182/blood-2018-99-110661

Published: 2018

Journal Articles

Paper or Plastic: RT-PCR of BCR-ABL from Blood Spots Stored and Shipped on Paper

Olga Sala Torra, MD, Lan Beppu, Susan Branford, PhD, Linda Fletcher, BS, Gooley Ted, PhD, Amy L Paguirigan, PhD, Jordan Smith, Jerald P Radich, MD

Blood (2014) 124 (21): 4566.

https://doi.org/10.1182/blood.V124.21.4566.4566

Published: 2014

Journal Articles

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

Olga Sala Torra, MD, Megan Othus, PhD, David W Williamson, PhD, Brent L. Wood, MD PhD, Ilan Kirsch, MD, Harlan Robins, PhD, Margaret O'Donnell, Stephen J. Forman, Frederick R. Appelbaum, MD, Jerald P Radich, MD

Blood (2014) 124 (21): 2399.

https://doi.org/10.1182/blood.V124.21.2399.2399

Published: 2014

Journal Articles

CD52 Expression In Leukemic Stem/Progenitor Cells

Vivian G. Oehler, MD, Roland B. Walter, MD, PhD, Carrie Cummings, Olga Sala-Torra, MD, Derek L. Stirewalt, MD, Min Fang, MD, PhD, Jerald P. Radich, MD, Brent Wood, MD, PhD

Blood (2010) 116 (21): 2743.

https://doi.org/10.1182/blood.V116.21.2743.2743

Published: 2010

Journal Articles

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Anjali Advani, MD, Holly Gundacker, MS, Olga Sala-Torra, MD, Jerald Radich, MD, Raymond Lai, MD, PhD, Marilyn L. Slovak, PhD, Jeffrey E Lancet, MD, Steve Coutre, MD, Robert K Stuart, MD, Martha P. Mims, MD, PhD, Patrick Stiff, MD, Frederick R. Appelbaum, MD

Blood (2009) 114 (22): 3094.

https://doi.org/10.1182/blood.V114.22.3094.3094

Published: 2009

Journal Articles

Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens.

Olga Sala-Torra, MD, Paul J. Martin, MD, Barry Storer, PhD, Mohamed Sorror, MD, Rainer F. Storb, MD, Brenda M. Sandmaier, MD, Mary E.D. Flowers, MD

Blood (2006) 108 (11): 755.

https://doi.org/10.1182/blood.V108.11.755.755

Published: 2006

Journal Articles

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Olga Sala-Torra, MD, Holly M. Gundacker, Derek L. Stirewalt, MD, Paula A. Ladne, Era L. Pogosova-Agadjanyan, Marilyn L. Slovak, PhD, Cheryl L. Willman, MD, Shelly Heimfeld, PhD, David H. Boldt, MD, Jerald P. Radich, MD

Blood (2005) 106 (11): 336.

https://doi.org/10.1182/blood.V106.11.336.336

Published: 2005

NARROW

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

Paper or Plastic: RT-PCR of BCR-ABL from Blood Spots Stored and Shipped on Paper

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

CD52 Expression In Leukemic Stem/Progenitor Cells

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens.

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

Paper or Plastic: RT-PCR of BCR-ABL from Blood Spots Stored and Shipped on Paper

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

CD52 Expression In Leukemic Stem/Progenitor Cells

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens.

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only